Panmure Gordon restated their sell rating on shares of Abcam Plc (LON:ABC) in a research report released on Thursday morning. They currently have a GBX 680 ($8.56) target price on the stock.

Other research analysts have also recently issued reports about the company. Stifel Nicolaus reissued a hold rating and issued a GBX 890 ($11.20) target price on shares of Abcam Plc in a research report on Tuesday, April 4th. Numis Securities Ltd raised Abcam Plc to an add rating and set a GBX 912 ($11.48) price objective on the stock in a research report on Tuesday, April 4th. JPMorgan Chase & Co. lifted their price objective on Abcam Plc from GBX 678 ($8.53) to GBX 864 ($10.87) and gave the company a neutral rating in a research report on Monday, March 27th. Finally, Peel Hunt assumed coverage on Abcam Plc in a research report on Wednesday, January 25th. They set a hold rating and a GBX 750 ($9.44) price objective on the stock. One research analyst has rated the stock with a sell rating and four have given a hold rating to the stock. The company currently has an average rating of Hold and a consensus price target of GBX 819.20 ($10.31).

Analyst Recommendations for Abcam Plc (LON:ABC)

Abcam Plc (LON:ABC) traded down 0.36% during trading on Thursday, reaching GBX 826.00. 375,791 shares of the company’s stock were exchanged. The stock’s market cap is GBX 1.67 billion. The firm has a 50 day moving average of GBX 854.11 and a 200-day moving average of GBX 836.38. Abcam Plc has a 12 month low of GBX 587.00 and a 12 month high of GBX 948.00.



TRADEMARK VIOLATION NOTICE: “Abcam Plc’s (ABC) “Sell” Rating Reaffirmed at Panmure Gordon” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/04/21/abcam-plcs-abc-sell-rating-reaffirmed-at-panmure-gordon.html.

The business also recently disclosed a dividend, which was paid on Thursday, April 13th. Stockholders of record on Thursday, March 16th were given a dividend of GBX 2.83 ($0.04) per share. The ex-dividend date of this dividend was Thursday, March 16th. This represents a dividend yield of 0.31%.

In related news, insider Alan Thomas Hirzel acquired 6,000 shares of the stock in a transaction dated Wednesday, March 22nd. The shares were purchased at an average cost of GBX 809 ($10.18) per share, with a total value of £48,540 ($61,095.03).

About Abcam Plc

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Receive News & Stock Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related stocks with our FREE daily email newsletter.